Home
JournalsCollections
For Authors For Reviewers For Editorial Board Members
Article Processing Charges Open Access
Ethics Advertising Policy
Editorial Policy Resource Center
Company Information Contact Us Membership Collaborators Partners
OPEN ACCESS

Research Progress and Reflection on New Drugs for the Treatment of Chronic Hepatitis B

  • Zhen-Zhou Long1 and
  • Qing-He Nie1,*
Gastroenterology & Hepatology Research   2020;2(4):125-131

doi: 10.53388/ghr2020-12-026

Published online:

 Author information

Citation: Long ZZ, Nie QH. Research Progress and Reflection on New Drugs for the Treatment of Chronic Hepatitis B. Gastroenterol & Hepatol Res. 2020;2(4):125-131. doi: 10.53388/ghr2020-12-026.

Abstract

Chronic hepatitis B (CHB) affects more than 257 million individuals with high liver-related morbidity and mortality worldwide. This review summarizes research progress and reflection on new drugs for the treatment of CHB. Some available HBV therapeutic strategies and their corresponding stages of development from preclinical to various clinical phases are indicated in this article. Through this review, the author aims to give us a comprehensive understanding of the global research trends and the latest progress of new drugs for treating chronic hepatitis B, so as to gain useful enlightenment.

Keywords

hepatitis B, chronic, new drug's research & development, covalently closed circular DNA (cccDNA), cure, reflection

About this Article

Cite this article
Long ZZ, Nie QH. Research Progress and Reflection on New Drugs for the Treatment of Chronic Hepatitis B. Gastroenterol & Hepatol Res. 2020;2(4):125-131. doi: 10.53388/ghr2020-12-026.
Copy Export to RIS Export to EndNote
Article History
Received Revised Accepted Published
December 12, 2020
DOI http://dx.doi.org/10.53388/ghr2020-12-026